The US Diabetes Drug Therapy Market holds a significant position globally, supported by a high prevalence of diabetes, strong healthcare spending, and widespread adoption of advanced treatment options. The increasing use of innovative drug classes, including GLP-1 receptor agonists, SGLT2 inhibitors, and next-generation insulin therapies, is driving market growth across the country. Favorable...